Company Filing History:
Years Active: 2014
Title: Antonio Abelino De Leon Martin: Innovator in Pharmaceutical Chemistry
Introduction
Antonio Abelino De Leon Martin is a notable inventor based in Barbera del Valles, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new methods for drug preparation. His innovative approach has led to advancements that are beneficial for the treatment of various medical conditions.
Latest Patents
Antonio holds a patent for a process for preparing rufinamide intermediate. This invention refers to an improved method for the preparation of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid, which is substantially free of its 3H-I isomer. The invention also encompasses the use of this intermediate for the preparation of Rufinamide and for obtaining a new polymorphic form of Rufinamide, designated as Form R-5. This new polymorph exhibits good stability and appropriate physicochemical properties for industrial manipulation. Form R-5 is particularly suitable for use as a pharmaceutical for the treatment of convulsions, especially in epilepsy cases.
Career Highlights
Antonio is associated with Laboratorios Lesvi, S.L., where he applies his expertise in pharmaceutical development. His work has been instrumental in enhancing the quality and efficacy of medications available for patients. His dedication to innovation in drug formulation has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Antonio has collaborated with notable colleagues such as Jordi Bessa Bellmunt and Juan Huguet Clotet. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Antonio Abelino De Leon Martin is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug preparation methods. His contributions are vital for the ongoing development of effective treatments for epilepsy and other medical conditions.